Point72 Asset Management’s Keros Therapeutics KROS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6
| Closed | -$59 | – | 1601 |
|
|
2025
Q1 | $59 | Sell |
6
-1,586
| -100% | -$15.6K | ﹤0.01% | 1217 |
|
|
2024
Q4 | $25.2K | Sell |
1,592
-945,978
| -100% | -$15M | ﹤0.01% | 1220 |
|
|
2024
Q3 | $55M | Buy |
947,570
+577,220
| +156% | +$33.5M | 0.14% | 159 |
|
|
2024
Q2 | $16.9M | Sell |
370,350
-601,531
| -62% | -$27.5M | 0.04% | 389 |
|
|
2024
Q1 | $64.3M | Buy |
971,881
+890,651
| +1,096% | +$59M | 0.16% | 134 |
|
|
2023
Q4 | $3.23M | Sell |
81,230
-68,503
| -46% | -$2.72M | 0.01% | 795 |
|
|
2023
Q3 | $4.77M | Sell |
149,733
-199,927
| -57% | -$6.37M | 0.01% | 717 |
|
|
2023
Q2 | $14M | Buy |
349,660
+144,000
| +70% | +$5.79M | 0.04% | 442 |
|
|
2023
Q1 | $8.78M | Sell |
205,660
-314,876
| -60% | -$13.4M | 0.03% | 519 |
|
|
2022
Q4 | $25M | Buy |
520,536
+428,696
| +467% | +$20.6M | 0.09% | 270 |
|
|
2022
Q3 | $3.46M | Buy |
+91,840
| New | +$3.46M | 0.01% | 696 |
|
|
2022
Q1 | – | Sell |
-63,028
| Closed | -$3.69M | – | 1179 |
|
|
2021
Q4 | $3.69M | Sell |
63,028
-85,572
| -58% | -$5.01M | 0.01% | 685 |
|
|
2021
Q3 | $5.88M | Sell |
148,600
-254,007
| -63% | -$10M | 0.03% | 587 |
|
|
2021
Q2 | $17.1M | Buy |
402,607
+179,445
| +80% | +$7.62M | 0.08% | 303 |
|
|
2021
Q1 | $13.7M | Buy |
223,162
+9,362
| +4% | +$576K | 0.06% | 336 |
|
|
2020
Q4 | $15.1M | Buy |
213,800
+133,000
| +165% | +$9.38M | 0.07% | 329 |
|
|
2020
Q3 | $3.12M | Sell |
80,800
-71,500
| -47% | -$2.76M | 0.02% | 599 |
|
|
2020
Q2 | $5.71M | Buy |
+152,300
| New | +$5.71M | 0.04% | 436 |
|